FRM
SUPN icon

Fox Run Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Fox Run Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$640K Buy
+12,976
New +$661K 0.11% 330
2025
Q1 		– Sell
-35,900
Closed -$1.3M – 1217
2024
Q4 		$1.3M Buy
+35,900
New +$1.26M 0.24% 90
2019
Q2 		– Sell
-16,034
Closed -$562K – 617
2019
Q1 		$562K Buy
+16,034
New +$597K 0.32% 82
2018
Q2 		– Sell
-16,075
Closed -$736K – 902
2018
Q1 		$736K Sell
16,075
-5,900
-27% -$246K 0.18% 175
2017
Q4 		$876K Buy
+21,975
New +$868K 0.26% 91
2016
Q1 		– Sell
-15,400
Closed -$207K – 542
2015
Q4 		$207K Buy
+15,400
New +$238K 0.16% 305

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return